Aposave writes article for the Clinical Trial Supply Handbook 2021
In the article, Business Development Director, Ian Hoban, addresses the results of a recent clinical trial supplies survey, while highlighting the threat of the “COVID timebomb”.
Survey results and the “COVID timebomb”
In September 2020, the Aposave team attended the GCSG 2020 conference. Here, we conducted a clinical trial comparator survey to gain an insight into the key issues and challenges faced by clinical supplies executives.
The main results of the survey were featured in an article in this year’s Clinical Trial Supply Handbook.
In the article, Ian Hoban further breaks down the threat of the “COVID timebomb”.
